A detailed history of Martingale Asset Management L P transactions in Biogen Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 55,772 shares of BIIB stock, worth $8.31 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
55,772
Previous 54,341 2.63%
Holding current value
$8.31 Million
Previous $12.6 Million 14.19%
% of portfolio
0.25%
Previous 0.28%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $270,559 - $338,860
1,431 Added 2.63%
55,772 $10.8 Million
Q2 2024

Aug 12, 2024

SELL
$190.52 - $236.72 $619,380 - $769,576
-3,251 Reduced 5.64%
54,341 $12.6 Million
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $982,712 - $1.24 Million
-4,635 Reduced 7.45%
57,592 $12.4 Million
Q4 2023

Feb 12, 2024

SELL
$222.59 - $267.94 $450,744 - $542,578
-2,025 Reduced 3.15%
62,227 $16.1 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $391,095 - $441,414
1,544 Added 2.46%
64,252 $16.5 Million
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $4,404 - $5,088
-16 Reduced 0.03%
62,708 $17.9 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $9.62 Million - $11 Million
37,482 Added 148.49%
62,724 $17.4 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $8.32 Million - $10.1 Million
-32,978 Reduced 56.64%
25,242 $6.99 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $366,211 - $504,973
1,881 Added 3.34%
58,220 $15.5 Million
Q2 2022

Aug 11, 2022

BUY
$187.54 - $223.02 $10.6 Million - $12.6 Million
56,339 New
56,339 $11.5 Million
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $1.95 Million - $2.28 Million
-8,008 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $19.4 Million - $29.2 Million
-82,069 Reduced 91.11%
8,008 $1.96 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $6.99 Million - $8.07 Million
26,409 Added 41.48%
90,077 $25.6 Million
Q2 2020

Aug 10, 2020

BUY
$258.66 - $342.55 $16 Million - $21.1 Million
61,708 Added 3148.37%
63,668 $17 Million
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $537 - $682
-2 Reduced 0.1%
1,960 $620,000
Q4 2019

Feb 10, 2020

SELL
$220.06 - $304.07 $880,680 - $1.22 Million
-4,002 Reduced 67.1%
1,962 $582,000
Q3 2019

Nov 13, 2019

SELL
$217.44 - $243.88 $652,320 - $731,640
-3,000 Reduced 33.47%
5,964 $1.39 Million
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $504,367 - $555,956
-2,300 Reduced 20.42%
8,964 $0
Q4 2018

Feb 11, 2019

BUY
$278.5 - $352.75 $557 - $705
2 Added 0.02%
11,264 $3.39 Million
Q3 2018

Nov 09, 2018

SELL
$293.51 - $383.83 $146,461 - $191,531
-499 Reduced 4.24%
11,262 $0
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $51,761 - $61,688
201 Added 1.74%
11,761 $0
Q1 2018

May 11, 2018

SELL
$260.13 - $367.91 $520 - $735
-2 Reduced 0.02%
11,560 $0
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $29,841 - $33,424
-97 Reduced 0.83%
11,562 $0
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $3.28 Million - $3.84 Million
11,659
11,659 $3.65 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.